Shaping the Future of Treating Deep Venous Disease

The Vesper DUO Venous Stent System® is designed to be the next generation venous stent portfolio uniquely engineered to address the multiple anatomical challenges of the deep venous system for the broad range of patients with Chronic Venous Insufficiency (CVI).

The VIVID Clinical Trial is currently recruiting adult patients that have CVI and are eligible for a venous stent in their iliac or common femoral veins.

Our Stent Portfolio VIVID Trial Details

Venous News Interview with Dr. Mahmood Razavi, VIVID trial national PI

Dr. Razavi discusses the VIVID trial and how it will provide new insights for venous stenting and how using DUO-HYBRID and DUO-EXTEND may reduce the need to mix and match stents.

Vesper Medical in the news

Stacy Enxing Seng Joins the Vesper Medical Board of Directors Read More >

Vesper Medical Announces First Enrollment in the VIVID Trial Read More >

Vesper Medical Announces $37 Million Financing with Vensana Capital and Gilde Healthcare to Complete Development of its Duo Venous Stent System™ Read More >

Vesper Medical Logo

Contact us for information about Vesper Medical and the VIVID clinical study

* Required Field

Scroll to Top